Aspirin 75mg Tablet Franchise in Ahmedabad

Low-Dose Aspirin Tablet Supplier in Bangalore

Antiplatelet Medicine Distributor in Hyderabad

Aspirin 75mg Tablet Franchise Opportunity in Jaipur

Cardiovascular Medicine Stockist in Mumbai
Aspirin Tablet Export & Manufacturing in Chandigarh

Home/Products /aspirin-75mg-tablet

Aspofoli 75 Tablet

Composition : Aspirin (75mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹0/-

Please Contact For Best Price

Aspofoli 75 Tablet contains Aspirin 75mg, a low-dose antiplatelet formulation widely prescribed for long-term heart health management. It helps prevent platelet aggregation, reducing the risk of blood clots, heart attack, and stroke, making it a vital medicine for patients with cardiovascular conditions.

This low-dose strength is ideal for daily maintenance therapy, providing the benefits of aspirin while minimizing side effects such as gastric irritation or bleeding. Doctors frequently recommend it for patients with coronary artery disease, post-angioplasty care, or high-risk individuals requiring preventive therapy. Its reliable action ensures consistent cardiovascular protection.

For distributors and wholesalers, Aspofoli 75 Tablet is a high-demand essential medicine, especially in cardiac care. Continuous prescriptions and long-term use ensure repeated orders, creating stable business opportunities. Hospitals, clinics, and pharmacies consistently stock this product to meet patient needs.

Adding Aspofoli 75 Tablet to your portfolio enhances your cardiovascular segment and opens avenues for bulk supply, institutional orders, export, and third-party manufacturing partnerships. Its strong market relevance, essential therapy status, and consistent demand make it a profitable and strategic addition for any distributor or stockist.

Read More

About the Product

Aspofoli 75 Tablet contains Aspirin 75mg, a low-dose antiplatelet formulation widely prescribed for long-term heart health management. It helps prevent platelet aggregation, reducing the risk of blood clots, heart attack, and stroke, making it a vital medicine for patients with cardiovascular conditions.

This low-dose strength is ideal for daily maintenance therapy, providing the benefits of aspirin while minimizing side effects such as gastric irritation or bleeding. Doctors frequently recommend it for patients with coronary artery disease, post-angioplasty care, or high-risk individuals requiring preventive therapy. Its reliable action ensures consistent cardiovascular protection.

For distributors and wholesalers, Aspofoli 75 Tablet is a high-demand essential medicine, especially in cardiac care. Continuous prescriptions and long-term use ensure repeated orders, creating stable business opportunities. Hospitals, clinics, and pharmacies consistently stock this product to meet patient needs.

Adding Aspofoli 75 Tablet to your portfolio enhances your cardiovascular segment and opens avenues for bulk supply, institutional orders, export, and third-party manufacturing partnerships. Its strong market relevance, essential therapy status, and consistent demand make it a profitable and strategic addition for any distributor or stockist.

Some patients may experience stomach discomfort, acidity, nausea, or mild bleeding tendencies such as gum or nosebleeds. Rarely, severe gastrointestinal bleeding, allergic reactions, or tinnitus may occur.

It is indicated for the prevention of heart attack, stroke, and transient ischemic attacks (TIAs). It also supports patients with coronary artery disease, post-angioplasty, or bypass surgery, and those with cardiovascular risk factors such as hypertension, diabetes, or high cholesterol.

Use only under medical supervision. Avoid in patients with active ulcers, bleeding disorders, aspirin allergy, or severe liver/kidney disease. Do not combine with other blood thinners without medical advice. Not recommended in children due to the risk of Reye’s syndrome.

Store in a cool, dry place below 25°C, protected from moisture and sunlight. Keep out of reach of children.

Get in Touch